Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Ingevity Corp (NGVT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,785,000
  • Shares Outstanding, K 41,969
  • Annual Sales, $ 1,134 M
  • Annual Income, $ 169,100 K
  • 36-Month Beta 1.55
  • Price/Sales 4.19
  • Price/Cash Flow 20.53
  • Price/Book 14.13

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate 0.95
  • Number of Estimates 5
  • High Estimate 1.02
  • Low Estimate 0.89
  • Prior Year 0.79
  • Growth Rate Est. (year over year) +20.25%

Price Performance

See More
Period Period Low Period High Performance
1-Month
87.70 +30.98%
on 01/23/19
120.41 -4.60%
on 02/21/19
+24.03 (+26.45%)
since 01/22/19
3-Month
74.98 +53.20%
on 12/26/18
120.41 -4.60%
on 02/21/19
+19.59 (+20.56%)
since 11/21/18
52-Week
70.71 +62.45%
on 04/02/18
120.41 -4.60%
on 02/21/19
+37.50 (+48.47%)
since 02/22/18

Most Recent Stories

More News
Century Aluminum (CENX) Earnings & Sales Beat Estimates in Q4

The relationship between aluminum and alumina prices hurts Century Aluminum's (CENX) financial performance in Q4.

MOS : 32.30 (-2.62%)
KL : 34.90 (-3.11%)
NGVT : 114.87 (+0.75%)
CENX : 9.26 (-0.32%)
Albemarle (ALB) in Focus: Stock Moves 7.8% Higher

Albemarle (ALB) saw a big move last session, as its shares jumped nearly 8% on the day, amid huge volumes.

NGVT : 114.87 (+0.75%)
ALB : 89.18 (-0.09%)
Input Costs, Higher Maintenance Downtime Weigh on WestRock

Input cost inflation, higher maintenance downtime and steps taken to reduce inventory to match demand is likely to dent WestRock's (WRK) near-term results.

WRK : 39.27 (+0.03%)
ICL : 5.60 (+0.90%)
NGVT : 114.87 (+0.75%)
GRA : 77.65 (+0.14%)
Higher Costs & Debt Levels to Hurt International Flavors

International Flavors & Fragrances Inc. (IFF) is likely to be plagued by rising costs and interest expenses owing to higher debt levels.

ICL : 5.60 (+0.90%)
NGVT : 114.87 (+0.75%)
GRA : 77.65 (+0.14%)
IFF : 128.23 (-0.40%)
Ingevity (NGVT) Tops Earnings & Revenue Estimates in Q4

Ingevity (NGVT) gained from increased volumes, better price and mix, and reduced raw materials costs in Q4.

MOS : 32.30 (-2.62%)
KL : 34.90 (-3.11%)
ICL : 5.60 (+0.90%)
NGVT : 114.87 (+0.75%)
Ingevity Corporation (NGVT) Q4 Earnings and Revenues Beat Estimates

Ingevity Corporation (NGVT) delivered earnings and revenue surprises of 37.18% and 6.19%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?

NGVT : 114.87 (+0.75%)
Ingevity completes acquisition of Capa(TM) caprolactone division of Perstorp Holding AB

Ingevity Corporation (NYSE: NGVT) has completed its acquisition of the Capa(TM) caprolactone division of Perstorp Holding AB for a cash purchase price of EUR578.9 million ($652.5 million)....

NGVT : 114.87 (+0.75%)
Ingevity reports preliminary fourth quarter and full year 2018 financial results

--Net sales of $278.6 million were up 21.4 percent versus the prior year quarter's sales of $229.5 million

NGVT : 114.87 (+0.75%)
Near-Term Prospects Cloudy for Specialty Chemical Stocks

Near-Term Prospects Cloudy for Specialty Chemical Stocks

NGVT : 114.87 (+0.75%)
ICL : 5.60 (+0.90%)
KWR : 212.05 (+0.42%)
FOE : 17.90 (+0.11%)
Ingevity Corporation (NGVT) Earnings Expected to Grow: Should You Buy?

Ingevity Corporation (NGVT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

NGVT : 114.87 (+0.75%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators mostly agree with the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade NGVT with:

Business Summary

Ingevity Corporation provides specialty chemicals, carbon materials and technologies. The Company's operating segments consists of Performance Materials and Performance Chemicals. Performance Chemicals segment products consists of asphalt paving, adhesives, agrochemical dispersants, printing inks, lubricants,...

See More

Key Turning Points

2nd Resistance Point 116.99
1st Resistance Point 115.93
Last Price 114.87
1st Support Level 113.31
2nd Support Level 111.75

See More

52-Week High 120.41
Last Price 114.87
Fibonacci 61.8% 101.42
Fibonacci 50% 95.56
Fibonacci 38.2% 89.70
52-Week Low 70.71

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar